HCW Biologics (HCWB) Price to Book (2021 - 2026)

HCW Biologics (HCWB) has reported Price to Book for 6 consecutive years, with 0.89 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book rose 103.95% year-over-year to 0.89; the trailing twelve-month figure through Jun 2026 stood at 0.89 (up 103.95% YoY), and the FY2025 full-year result was 0.12, up 124.86% from the prior year.
• Price to Book climbed to 0.89 in Q2 2026 per HCWB's latest filing, from 0.12 in the prior quarter.
• Across five years, Price to Book topped out at 1.26 in Q1 2024 and bottomed at 22.61 in Q2 2025.
• Historically, Price to Book has averaged 1.73 across 5 years, with a median of 0.28 in 2022.
• The sharpest annual moves came in 2024 and 2025: Price to Book surged 391.29% in 2024, then plunged 3391.69% in 2025.
• Over 5 years, Price to Book stood at 0.31 in 2022, then jumped by 87.45% to 0.57 in 2023, then sank by 186.0% to 0.49 in 2024, then soared by 124.86% to 0.12 in 2025, then surged by 627.33% to 0.89 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 0.89, 0.12, and 0.79 for Q2 2026, Q4 2025, and Q3 2025 respectively.